Skip to main content
SpringerLink
Log in

The T-786C, G894T, and intron 4 VNTR (4a/b) polymorphisms of the endothelial nitric oxide synthase gene in prostate cancer cases

  • Human Genetics
  • Published:
Russian Journal of Genetics Aims and scope Submit manuscript

Abstract

In previously conducted some studies it has been revealed that nitric oxide (NO) and nitric oxide synthase (NOS) system play a significant role in carcinogenesis. Nitric oxide (NO) is regulated by endothelial nitric oxide synthase (eNOS) enzyme which is one of the isoenzymes of NO synthase (NOS). In this study we have tried to come to a conclusion about whether eNOS gene T-786C, G894T and intron 4 VNTR (4a/b) polymorphisms might be considered as a risk factor causing prostate cancer (PCa) or not. A total of 200 subjects were included in this research. 84 patients with PCa (mean age 70.0 ± 6.4) and 116 healthy controls (mean age 69.9 ± 7.5) were recruited in this case-control study. Genomic DNA was extracted using the QIAamp DNA Blood Mini Kit (QIAGEN GmbH, Maryland, USA), according to the manufacturer’s guidelines. The T-786C, G894T and intron 4 VNTR (4a/b) polymorphisms were amplified using polymerase chain reation (PCR), detected by restriction fragment length polymorphism (RFLP). For T-786C polymorphism CC genotype [odds ratio (OR): 0.34, 95% confidence interval (CI): 0.15–0.78, P = 0.009)] and allele frequency (OR: 0.631, CI: 0.421–0.946, P = 0.026) is significant for control. In patients with PCa eNOS G894T polymorphism, both GT (OR: 0.069, CI: 0.027–0.174; P = 0.0001) and TT (OR: 0.040, CI: 0.013–0.123; P = 0.0001) genotype distribution, and also T allele frequency (OR: 0.237, CI: 0.155–0.362, P = 0.0001) were considered significant statistically. While genotype distribution for the other polymorphism eNOS, intron 4 VNTR (4a/b), is insignificant statistically, “a” allele frequency was found out to be significant (OR: 2.223, CI: 1.311–3.769, P = 0.003). In this study we indicated that genotype and allele frequencies of eNOS T-786C and G894T polymorphisms are statistically significant in patients with PCa. eNOS T-786C and G894T polymorphisms may be associated with PCa susceptibility in the Turkish population. In contrast, intron 4 VNTR (4a/b) polymorphism may not be related to PCa susceptibility in these patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Loktionov, A., Common gene polymorphisms, cancer progression and prognosis, Cancer Lett., 2004, vol. 208, pp. 1–33.

    Article  CAS  Google Scholar 

  2. Romanyuk, O.P., Nikitchenko, N.V., Savina, N.V., et al., The polymorphism of DNA repair genes XPD, XRCC1, OGG1,and ERCC6, life expectancy, and the inclination to smoke, Russ. J. Genet., 2014, vol. 50, no. 8, pp. 860–869.

    CAS  Google Scholar 

  3. Ying, L. and Hofseth, L.J., An emerging role for endothelial nitric oxide synthase in chronic inflammation and cancer, Cancer Res., 2007, vol. 67, no. 4, pp. 1407–1410.

    Article  CAS  PubMed  Google Scholar 

  4. Safarinejad, M.R., Safarinejad, S., and Shafiei, N., Effects of the T-786C, G894T, and intron 4 VNTR (4a/b) polymorphisms of the endothelial nitric oxide synthase gene on the risk of prostate cancer, Urol. Oncol., 2013, vol. 31, no. 7, pp. 1132–1140.

    CAS  PubMed  Google Scholar 

  5. Mustafina, O.E., Shagisultanova, E.I., Nasybullin, T.R., et al., Endothelial nitric oxide synthase gene minisatellite polymorphism in populations of the Volga–Ural Region and analysis of its association with myocardial Infarction and essential hypertension, Russ. J. Genet., 2001, vol. 37, no. 5, pp. 546–552.

    Article  CAS  Google Scholar 

  6. Amasyali, A.S., Kucukgergin, C., Erdem, S., et al., Nitric oxide synthase (eNOS4a/b) gene polymorphism is associated with tumor recurrence and progression in superficial bladder cancer cases, J. Urol., 2012, vol. 188, pp. 2398–2403.

    Article  CAS  PubMed  Google Scholar 

  7. Belgorosky, D., Langle, Y., Mc Cormick, B.P., et al., Inhibition of nitric oxide is a good therapeutic target for bladder tumors that express iNOS, Nitric Oxide, 2014, vol. 36, pp. 11–18.

    Article  CAS  PubMed  Google Scholar 

  8. Verim, L., Topta, B., Özkan, N.E., et al., Possible relation between the NOS3 gene GLU298ASP polymorphism and bladder cancer in Turkey, Asian Pacific J. Cancer Prev., 2013, vol. 14, no. 2, pp. 665–668.

    Article  Google Scholar 

  9. Akhmadishina, L.Z., Gilyazova, I.R., Kutlyeva, L.R., et al., DNA repair XPCC1 and XPD genes polymorphism as associated with the development of bladder cancer and renal cell carcinoma, Russ. J. Genet., 2014, vol. 50, no. 4, pp. 421–429.

    Article  CAS  Google Scholar 

  10. Tong, X. and Li, H., eNOS protects prostate cancer cells from TRAIL-induced apoptosis, Cancer Lett., 2004, vol. 210, pp. 63–71.

    Article  CAS  PubMed  Google Scholar 

  11. Beebe-Dimmer, J.L., Isaacs, W.B., Zuhlke, K.A., et al., Prevalence of the HOXB13 G84E prostate cancer risk allele in men treated with radical prostatectomy, BJU Internat., 2014, vol. 113, pp. 830–835.

    Article  CAS  Google Scholar 

  12. Ruddon, R.W., Cancer Biology, New York: Oxford University Press, 1995, 3rd ed.

    Google Scholar 

  13. Vanaja, D.K., Cheville, J.C., Iturria, S.J., et al., Transcriptional silencing of zinc finger protein 185 identified by expression profiling is associated with prostate cancer progression, Cancer Res., 2003, vol. 63, pp. 3877–3882.

    CAS  PubMed  Google Scholar 

  14. Singh, D., Febbo, P.G., Ross, et al., Gene expression correlates of clinical prostate cancer behavior, Cancer Cell., 2002, vol. 1, pp. 203–209.

    CAS  Google Scholar 

  15. Nihei, N., Ohta, S., Kuramochi, H., et al., Metastasis suppressor gene(s) for rat prostate cancer on the long arm of human chromosome 7, Genes Chromosomes Cancer, 1999, vol. 24, no. 1, pp. 1–8.

    Article  CAS  PubMed  Google Scholar 

  16. Bushueva, O.Y., Stetskaya, T.A,, Korogodina, T.V., et al., The synergic effect of the E298D polymorphism of the endothelial nitric oxide synthase gene and smoking status on the risk of cerebral stroke, Russ. J. Genet., 2015, vol. 51, no. 2, pp. 204–209.

    Article  CAS  Google Scholar 

  17. Thameem, F., Puppala, S., Arar, N.H., et al., Endothelial nitric oxide synthase (eNOS) gene polymorphisms and their association with type 2 diabetes-related traits in Mexican Americans, Diab. Vasc. Dis. Res., 2008, vol. 5, no. 2, pp. 109–113.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Babushkina, N.P. and Kucher, A.N., Functional role of VNTR polymorphism of human genes, Russ. J. Genet., 2011, vol. 47, no. 6, pp. 637–645.

    Article  CAS  Google Scholar 

  19. Tecder, Ü.M., Karabulut, H.G., Gümü-Akay, G., et al., Endothelial nitric oxide synthase gene polymorphism in gastric cancer, Turk. J. Gastroenterol., 2010, vol. 21, pp. 338–344.

    Article  Google Scholar 

  20. Arikan, S., Cacina, C., Guler, E., et al., The effects of NOS3 Glu298Asp variant on colorectal cancer risk and progression in Turkish population, Mol. Biol. Rep., 2012, vol. 39, pp. 3245–3249.

    Article  CAS  PubMed  Google Scholar 

  21. Matyar, S., Attila, G., Acartürk, E., et al., eNOS gene intron 4 a/b VNTR polymorphism is a risk factor for coronary artery disease in Southern Turkey, Clin. Chim. Acta, 2005, vol. 354, nos. 1–2, pp. 153–158.

    Article  CAS  PubMed  Google Scholar 

  22. Berdeli, A., Sekuri, C., Çam, F.S., et al., Association between the eNOS (Glu298Asp) and the RAS genes polymorphisms and premature coronary artery disease in a Turkish population, Clin. Chim. Acta, 2005, vol. 351, nos. 1–2, pp. 87–94.

    Article  CAS  PubMed  Google Scholar 

  23. Ramírez-Patiño, R., Figuera, L.E., Puebla-Pérez L.E., et al., Intron 4 VNTR (4a/b) polymorphism of the endothelial nitric oxide synthase gene is associated with breast cancer in Mexican women, J. Korean Med. Sci., 2013, vol. 28, pp. 1587–1594.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Abolhalaj, M., Amoli, M.M., and Amiri, P., eNOS gene variant in patients with coronary artery disease, J. Biomarker, 2013, ID 403783, 1–6.

    Google Scholar 

  25. Rahimi, Z. and Nourozi-Rad, R., Association of endothelial nitric oxide synthase gene variant (G894T) with coronary artery disease in Western Iran, Angiology, 2012, vol. 63, no. 2, pp. 131–137.

    Article  CAS  PubMed  Google Scholar 

  26. Ragia, G., Nikolaidis, E., Tavridou, A., et al., Endothelial nitric oxide synthase gene polymorphisms–786T > C and 894G > T in coronary artery bypass graft surgery patients, Hum. Genomics, 2010, vol. 4, no. 6, pp. 375–383.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. anli, O., Kucukgergin, C., Gokpinar, M., et al., Despite the lack of association between different genotypes and the presence of prostate cancer, endothelial nitric oxide synthase a/b (eNOS4a/b) polymorphism may be associated with advanced clinical stage and bone metastasis, Urol. Oncol., 2011, vol. 29, pp. 183–188.

    Google Scholar 

  28. Medeiros, R., Morais, A., Vasconcelos, A., et al., Endothelial nitric oxide synthase gene polymorphisms and the shedding of circulating tumor cells in the blood of prostate cancer patients, Cancer Lett., 2003, vol. 189, pp. 85–90.

    Article  CAS  PubMed  Google Scholar 

  29. Medeiros, R., Morais, A., Vasconcelos, A., et al., Endothelial nitric oxide synthase gene polymorphisms and genetic susceptibility to prostate cancer, Eur. J. Cancer Prev., 2002, vol. 11, no. 4, pp. 343–350.

    Article  CAS  PubMed  Google Scholar 

  30. Safarinejad, M.R., Shafiei, N., and Safarinejad, S., The role of endothelial nitric oxide synthase (eNOS) T-786C, G894T, and 4a/b genepolymorphisms in the risk of idiopathic male infertility, Mol. Reprod. Dev., 2010, vol. 77, no. 8, pp. 720–727.

    CAS  Google Scholar 

  31. Medeiros, R.M., Morais, A., Vasconcelos, A., Costa, S., Pinto, D., Oliveira, J., Ferreira, P., and Lopes, C., Outcome in prostate cancer: association with endothelial nitric oxide synthase Glu-Asp298 polymorphism at exon 7, Clin. Cancer Res., 2002, vol. 8, no. 11, pp. 3433–4337.

    CAS  PubMed  Google Scholar 

  32. Marangoni, K., Neves, A.F., Cardoso, A.M., et al., The endothelial nitric oxide synthase Glu-298-Asp polymorphism and its mRNA expression in the peripheral blood of patients with prostate cancer and benign prostatic hyperplasia, Cancer Detect. Prev., 2006, vol. 30, no. 1, pp. 7–13.

    Article  CAS  PubMed  Google Scholar 

  33. Ziaei, S.A., Samzadeh, M., Jamaldini, S.H., et al., Endothelial nitric oxide synthase Glu298Asp polymorphism as a risk factor for prostate cancer, Int. J. Biol. Markers, 2013, vol. 28, no. 1, pp. 43–48.

    Article  CAS  PubMed  Google Scholar 

  34. Zhang, Y., Jia, Q., He, Q., et al., The Glu298Asp polymorphism in the NOS3 gene and the risk of prostate cancer, Tumour Biol., 2014, vol. 35, no. 5, pp. 4735–4739.

    Article  CAS  PubMed  Google Scholar 

  35. Zhao, C., Yan, W., Zu, X., et al., Association between endothelial nitric oxide synthase 894G>T polymorphism and prostate cancer risk: a meta-analysis of literature studies, Tumour Biol., 2014, vol. 35, no. 12, pp. 11727–11733.

    Article  CAS  PubMed  Google Scholar 

  36. Wu, X., Wang, Z.F., Xu, Y., et al., Association between three eNOS polymorphisms and cancer risk: a metaanalysis, Asian Pacific J. Cancer Prev., 2014, vol. 15, no. 13, pp. 5317–5324.

    Article  Google Scholar 

  37. Lin, Z., Chen, S., Ye, C., and Zhu, S., Nitric oxide synthase expression in human bladder cancer and its relation to angiogenesis, Urol. Res., 2003, vol. 31, no. 4, pp. 232–235.

    Article  CAS  PubMed  Google Scholar 

  38. Lee, K.M., Kang, D., Park, S.K., et al., Nitric oxide synthase gene polymorphisms and prostate cancer risk, Carcinogenesis, 2009, vol. 30, no. 4, pp. 621–625.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  39. Branković, A., Brajuković, G., Nikolić, Z., et al., Endothelial nitric oxide synthase gene polymorphisms and prostate cancer risk in Serbian population, Int. J. Exp. Pathol., 2013, vol. 94, no. 6, pp. 355–361.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Biology, Faculty of Science and Letters, University of Niğde, Niğde, 51240, Turkey

    S. B. Diler

  2. Department of Urology Clinic, Niğde State Hospital, Niğde, 51200, Turkey

    A. Öden

Authors
  1. S. B. Diler
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. Öden
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to S. B. Diler.

Additional information

The article was translated by the authors.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Diler, S.B., Öden, A. The T-786C, G894T, and intron 4 VNTR (4a/b) polymorphisms of the endothelial nitric oxide synthase gene in prostate cancer cases. Russ J Genet 52, 220–225 (2016). https://doi.org/10.1134/S1022795416020022

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1134/S1022795416020022

Keywords

Search

Navigation